4//SEC Filing
Perkins John R II 4
Accession 0001225208-10-020369
CIK 0001405197other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:49 PM ET
Size
16.1 KB
Accession
0001225208-10-020369
Insider Transaction Report
Form 4
Perkins John R II
Sr.VP & GM, Portfolio & US Bus
Transactions
- Sale
Common Stock
2010-09-01$22.30/sh−10,200$227,460→ 47,494 total - Exercise/Conversion
Common Stock
2010-09-02$11.00/sh+168,704$1,855,744→ 216,198 total - Exercise/Conversion
Options (right to buy)
2010-09-01$11.00/sh−8,100$89,100→ 44,620 totalExercise: $11.00From: 2009-04-01Exp: 2018-04-01→ Common Stock (8,100 underlying) - Exercise/Conversion
Common Stock
2010-09-02$11.00/sh+44,620$490,820→ 260,818 total - Exercise/Conversion
Options (right to buy)
2010-09-02$11.00/sh−168,704$1,855,744→ 42,176 totalExercise: $11.00From: 2006-12-06Exp: 2016-12-06→ Common Stock (168,704 underlying) - Exercise/Conversion
Common Stock
2010-09-01$11.00/sh+8,100$89,100→ 57,694 total - Exercise/Conversion
Options (right to buy)
2010-09-02$11.00/sh−44,620$490,820→ 0 totalExercise: $11.00From: 2009-04-01Exp: 2018-04-01→ Common Stock (44,620 underlying)
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 5,921 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The option is fully vested and immediately exercisable.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472130
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:49 PM ET
- Size
- 16.1 KB